Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice

Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice

NCT00927472 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation

NCT02060903 ·Status: COMPLETED ·Phase: PHASE3

Neem Lotion With Combing for Lice

NCT02974088 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice

NCT00927407 ·Status: COMPLETED ·Phase: PHASE1

Phototoxicity Potential of NatrOVA Creme Rinse - 1%

NCT00591331 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice

NCT03337490 ·Status: COMPLETED ·Phase: PHASE3

Bioequivalence Study for Benzyl Alcohol Lotion 5%.

NCT02624843 ·Status: COMPLETED ·Phase: PHASE3

A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5%

NCT03257943 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice

NCT00244439 ·Status: COMPLETED ·Phase: PHASE3

Clinical Endpoint Study of Ivermectin 0.5% Lotion

NCT03301649 ·Status: COMPLETED ·Phase: PHASE3

Randomized Controlled Trial Comparing Efficacy and Tolerance of Four Pediculicides

NCT00758823 ·Status: COMPLETED ·Phase: NA

NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers

NCT00605956 ·Status: COMPLETED ·Phase: PHASE1

Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic Keratosis

NCT01265602 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of NAFT900 in Children With Tinea Capitis

NCT02658292 ·Status: WITHDRAWN ·Phase: PHASE2

Assessment of the Phototoxic Potential of LEO 29102 Cream

NCT00958516 ·Status: COMPLETED ·Phase: PHASE1

Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2

NCT00659893 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Study of LAS41007 in the Treatment of Actinic Keratosis

NCT00991861 ·Status: COMPLETED ·Phase: PHASE2

Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel

NCT00239135 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis

NCT02120456 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis

NCT03148691 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

NCT02320149 ·Status: COMPLETED ·Phase: PHASE3

Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively

NCT02305888 ·Status: COMPLETED ·Phase: PHASE2

A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

NCT00700063 ·Status: COMPLETED ·Phase: PHASE2

A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis

NCT01922050 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Sarecycline Truncal Acne Safety and Efficacy Response

NCT05010538 ·Status: COMPLETED